FIELD: organic chemistry, medicine, neurology, pharmacy.
SUBSTANCE: invention relates to new derivatives of phenylpiperazine that are partial agonists of D2 receptors and can be used in treatment of the central nervous system disorders, in particular, Parkinson's disease. Invention describes derivatives of benzoxazolone of the formula (1): wherein R means group of the formula (a) or (b) , and their salts. Also, invention describes a method for preparing compounds of the formula (1), pharmaceutical composition based on compounds of the formula (1), method for treatment of Parkinson's disease and method for treatment of the central nervous system disorders, such as schizophrenia, anxiety state and depression based on compounds of the formula 91). Invention provides preparing new compounds possessing the useful biological properties.
EFFECT: improved methods for treatment, valuable medicinal properties of compounds and pharmaceutical composition.
5 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PHENYLPIPERAZINES | 2000 |
|
RU2246494C2 |
DERIVATIVES OF PIPERAZINE | 1998 |
|
RU2197488C2 |
DERIVATIVES OF PIPERAZINE AND PIPERIDINE AND METHOD OF THEIR SYNTHESIS | 1997 |
|
RU2178414C2 |
PIPERAZINE AND PIPERIDINE COMPOUNDS | 2001 |
|
RU2261250C2 |
POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR | 2012 |
|
RU2604737C2 |
SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS POSITIVE ALLOSTERIC MODULATOR D1 | 2020 |
|
RU2824581C2 |
SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS POSITIVE ALLOSTERIC MODULATOR D1 | 2020 |
|
RU2824527C2 |
PYRAZOLE DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2076100C1 |
TRISUBSTITUTED 1,2,4-TRIAZOLES | 2008 |
|
RU2474579C2 |
2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDROPYRROLO[1,2-A]PYRAZINE, METHOD OF TREATMENT, PHARMACEUTICAL COMPOSITION, AND INTERMEDIATES | 1996 |
|
RU2162470C2 |
Authors
Dates
2006-07-10—Published
2002-02-19—Filed